Impact Factor Journals

PISKLÁKOVÁ, B., J. FRIEDECKÁ, E. IVANOVOVÁ, E. HLIDKOVA, V. BEKÁREK, M. PRIDAVOK, A. KVASNIČKA, T. ADAM, D. FRIEDECKÝ
Rapid and efficient LC-MS/MS diagnosis of inherited metabolic disorders: a semi-automated workflow for analysis of organic acids, acylglycines, and acylcarnitines in urine. Clinical Chemistry and Laboratory Medicine. 2023, ISSN: 1434-6621, PMID: 37207286,
JEMELKOVA, J., M. STUCHLOVÁ HORYNOVÁ, P. KOSZTYU, K. ZACHOVÁ, J. ZADRAZIL, D. GALUSZKOVÁ, K. TAKAHASHI, J. NOVAK, M. RAŠKA
GalNAc-T14 may Contribute to Production of Galactose-Deficient Immunoglobulin A1, the Main Autoantigen in IgA Nephropathy. Kidney International Reports. 2023, 8(5), 1068-1075, ISSN: 2468-0249, PMID: 37180502,
KALITA, O., T. KAZDA, S. REGULI, R. JANCALEK, P. FADRUS, M. SLACHTA, P. POSPISIL, L. KRSKA, J. VRBKOVÁ, L. HRABALEK, M. SMRCKA, R. LIPINA
Effects of Reoperation Timing on Survival among Recurrent Glioblastoma Patients: A Retrospective Multicentric Descriptive Study. Cancers. 2023, 15(9), 2530, ISSN: 2072-6694, PMID: 37173996,
KANELLIS, D., A. ZISI, Z. ŠKROTT, B. LEMMENS, J. ESPINOZA, M. KOSAR, A. BJÖRKMAN, X. LI, S. ARAMPATZIS, J. BARTKOVA, M. ANDUJAR-SANCHEZ, O. FERNANDEZ-CAPETILLO, M. MISTRÍK, M. LINDSTROM, J. BÁRTEK
Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET. Cell Death and Differentiation. 2023, ISSN: 1350-9047, PMID: 37142656,
BUCHTOVÁ, T., L. BÉRESOVÁ, K. CHROMÁ, T. PLUHACEK, T. BERES, D. KACZOROVA, P. TARKOWSKI, J. BÁRTEK, M. MISTRÍK
Cannabis-derived products antagonize platinum drugs by altered cellular transport. Biomedicine & Pharmacotherapy. 2023, 163, 114801, ISSN: 0753-3322, PMID: 37137184,
MEDVEDÍKOVÁ, M., V. RANC, J. VANCO, P. ANZENBACHER
Highly Cytotoxic Copper(II) Mixed-Ligand Quinolinonato Complexes: Pharmacokinetic Properties and Interactions with Drug Metabolizing Cytochromes P450. Pharmaceutics. 2023, 15(4), 1314, ISSN: 1999-4923, PMID: 37111801, DATA.
ONDRUŠŠEK, R., B. KVOKACKOVA, K. KRYSTOFOVA, S. BRYCHTOVÁ, K. SOUCEK, J. BOUCHAL
Prognostic value and multifaceted roles of tetraspanin CD9 in cancer. Frontiers in Oncology. 2023, 13, 1140738, ISSN: 2234-943X, PMID: 37007105,
IVASECHKO, I., A. LOZYNSKYI, J. SENKIV, P. ROSZCZENKO, Y. KOZAK, N. FINIUK, O. KLYUCHIVSKA, N. KASHCHAK, N. MANKO, Z. MASLYAK, D. LESYK, A. KARKHUT, S. POLOKVOVYCH, R. CZARNOMYSY, O. SZEWCZYK, A. KOZYTSKIY, O. KARPENKO, D. KHYLUK, A. GZELLA, K. BIELAWSKI, A. BIELAWSKA, P. DŽUBÁK, S. GURSKÁ, M. HAJDÚCH, R. STOIKA, R. LESYK
Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone). European Journal of Medicinal Chemistry. 2023, 252, 115304, ISSN: 0223-5234, PMID: 37001390,
KOVALOVA, M., J. BARAKA, V. MIK, R. JORDA, M. LUO, H. SHAO, V. KRYŠTOF
A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022). Expert Opinion on Therapeutic Patents. 2023, 33(2), 67-87, ISSN: 1354-3776, PMID: 36975020,
KOVALOVA, M., L. HAVLICEK, S. DJUKIC, J. SKERLOVA, M. PERINA, T. POSPÍŠIL, E. ŘEZNÍČKOVÁ, P. ŘEZÁČOVÁ, R. JORDA, V. KRYŠTOF
Characterization of new highly selective pyrazolo[4,3-d]pyrimidine inhibitor of CDK7. Biomedicine & Pharmacotherapy. 2023, 161, 114492, ISSN: 0753-3322, PMID: 36931035,